Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 19.71% is 12% below its 5-year average of 22.44%, near the low end of its 5-year range (15.42%–30.32%).
As of the fiscal period ended Thursday, April 30, 2026. 4.45% below its 12-month average of 20.63%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
19.71%
DEBT TO ASSETS RATIO AVG TTM
20.63%
DEBT TO ASSETS RATIO AVG 3Y
21.48%
DEBT TO ASSETS RATIO AVG 5Y
21.68%
DEBT TO ASSETS RATIO AVG 10Y
26.68%
DEBT TO ASSETS RATIO AVG 15Y
24.00%
DEBT TO ASSETS RATIO AVG 20Y
25.99%
CURRENT VS TTM AVG
-4.45%
CURRENT VS 3Y AVG
-8.26%
CURRENT VS 5Y AVG
-9.10%
CURRENT VS 10Y AVG
-26.12%
CURRENT VS 15Y AVG
-17.89%
CURRENT VS 20Y AVG
-24.17%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+6696.38%
vs the sector median at left
The Cooper Companies, Inc.
Market Cap
$14.05B
Debt to Assets Ratio
19.71%
TTM Avg
20.63%
3Y Avg
21.48%
5Y Avg
21.68%
Market Cap
$14.92B
Debt to Assets Ratio
0.35%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.59B
Debt to Assets Ratio
0.50%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.58B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.94B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.58B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.05B | 19.71% | 20.63% | 21.48% | 21.68% |
| Solventum Corporation (SOLV)vs › | $14.92B | 0.35% | N/A | N/A | N/A |
| DaVita Inc. (DVA)vs › | $15.37B | 0.86% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.59B | 0.50% | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 0.02% | N/A | N/A | N/A |
| Revvity, Inc. (RVTY)vs › | $12.44B | 0.29% | N/A | N/A | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $15.94B | 0.13% | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $11.60B | 0.33% | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | 0.43% | N/A | N/A | N/A |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 0.17% | N/A | N/A | N/A |
Debt/Assets
19.7%
Debt/Equity
0.34
Current Ratio
1.89
Interest Coverage
6.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-04-30 | 19.71% |
| 2026-01-31 | 20.12% |
| 2025-10-31 | 22.46% |
| 2025-07-31 | 20.02% |
| 2025-04-30 | 20.83% |
| 2025-01-31 | 20.78% |
| 2024-10-31 | 20.98% |
| 2024-07-31 | 21.74% |
| 2024-04-30 | 22.52% |
| 2024-01-31 | 23.04% |
| 2023-10-31 | 22.04% |
| 2023-07-31 | 22.18% |
| 2023-04-30 | 22.88% |
| 2023-01-31 | 23.31% |
| 2022-10-31 | 24.05% |
| 2022-07-31 | 27.12% |
| 2022-04-30 | 29.84% |
| 2022-01-31 | 30.32% |
| 2021-10-31 | 15.42% |
| 2021-07-31 | 19.63% |
| 2021-04-30 | 22.33% |
| 2021-01-31 | 23.48% |
| 2020-10-31 | 30.62% |
| 2020-07-31 | 31.85% |
| 2020-04-30 | 33.23% |
| 2020-01-31 | 31.30% |
| 2019-10-31 | 29.11% |
| 2019-07-31 | 29.36% |
| 2019-04-30 | 31.06% |
| 2019-01-31 | 33.86% |
| 2018-10-31 | 33.09% |
| 2018-07-31 | 36.67% |
| 2018-04-30 | 38.72% |
| 2018-01-31 | 38.33% |
| 2017-10-31 | 24.14% |
| 2017-07-31 | 25.37% |
| 2017-04-30 | 29.20% |
| 2017-01-31 | 30.59% |
| 2016-10-31 | 29.80% |
| 2016-07-31 | 31.44% |
| 2016-04-30 | 31.33% |
| 2016-01-31 | 31.29% |
| 2015-10-31 | 30.25% |
| 2015-07-31 | 29.57% |
| 2015-04-30 | 30.68% |
| 2015-01-31 | 32.18% |
| 2014-10-31 | 31.01% |
| 2014-07-31 | 10.33% |
| 2014-04-30 | 10.41% |
| 2014-01-31 | 11.10% |
| 2013-10-31 | 10.99% |
| 2013-07-31 | 8.10% |
| 2013-04-30 | 10.80% |
| 2013-01-31 | 13.74% |
| 2012-10-31 | 12.71% |
| 2012-07-31 | 16.65% |
| 2012-04-30 | 12.15% |
| 2012-01-31 | 15.79% |
| 2011-10-31 | 14.50% |
| 2011-07-31 | 17.02% |
| 2011-04-30 | 21.07% |
| 2011-01-31 | 23.41% |
| 2010-10-31 | 24.20% |
| 2010-07-31 | 25.84% |
| 2010-04-30 | 28.41% |
| 2010-01-31 | 29.48% |
| 2009-10-31 | 30.62% |
| 2009-07-31 | 32.50% |
| 2009-04-30 | 35.17% |
| 2009-01-31 | 35.80% |
| 2008-10-31 | 34.97% |
| 2008-07-31 | 34.68% |
| 2008-04-30 | 35.79% |
| 2008-01-31 | 35.79% |
| 2007-10-31 | 34.24% |
| 2007-07-31 | 33.89% |
| 2007-04-30 | 34.50% |
| 2007-01-31 | 34.58% |
| 2006-10-31 | 31.57% |
| 2006-07-31 | 32.60% |
| 2006-04-30 | 33.04% |
| 2006-01-31 | 33.76% |
| 2005-10-31 | 32.34% |
| 2005-07-31 | 33.25% |
| 2005-04-30 | 33.30% |
| 2005-01-31 | 34.71% |
| 2004-10-31 | 20.42% |
| 2004-07-31 | 22.07% |
| 2004-04-30 | 24.00% |
| 2004-01-31 | 25.09% |
| 2003-10-31 | 26.34% |
| 2003-07-31 | 29.19% |
| 2003-04-30 | 27.09% |
| 2003-01-31 | 29.54% |
| 2002-10-31 | 28.65% |
| 2002-07-31 | 30.45% |
